Travere Therapeutics Inc
XNAS: TVTX
Travere Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...
Read More
15.87
0.34
(2.19%)
96,789
XNAS Volume
XNAS 30 Jul, 2025 10:24 AM (EDT)
Board Meeting
The next board meeting for Travere Therapeutics Inc is on 01 Aug 2025 for the purpose of Travere Therapeutics Inc Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Travere Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..